称重膳食治疗2型糖尿病的成本效果分析  

COST-EFFECTIVENESS ANALYSIS OF WEIGHED DIET THERAPY FOR TYPE 2 DIABETETS MELLITUS

作　　者：齐玉梅[1,2] 牛琛 王丽静 贾国瑜 肖慧娟[1] 张明[1,2] 郑平[1] 刘文苑 QI Yu-mei;NIU Chen;WANG Li-jing;JIA Guo-yu;XIAO Hui-juan;ZHANG Ming;ZHENG Ping;LIU Wen-yuan(‘Tianjin Third Central Hospital/Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases/Artificial CellEngineering Technology Research Center/Tianjin Institute of Hepatobiliary Disease,Tianjin 300170,China;Tianjin Clinical Nutrition Quality Control Center,Tianjin 300170,China)

机构地区：[1]天津市第三中心医院/天津市重症疾病体外生命支持重点实验室/天津市人工细胞工程技术研究中心/天津市肝胆疾病研究所,天津300170 [2]天津市临床营养质量控制中心,天津300170

出　　处：《营养学报》2022年第5期505-509,共5页Acta Nutrimenta Sinica

基　　金：天津市卫生健康委员会科技项目(No.ZC20115)。

摘　　要：目的 评价称重膳食疗法与非称重膳食疗法治疗2型糖尿病的成本-效果。方法 选取2020年1-12月住院的621例2型糖尿病患者作为研究对象,采用倾向性评分匹配均衡组间差异,基于电子病案系统收集成本、疗效、疾病情况等信息,并通过计算增量成本-效果比(incremental cost–effectiveness ratio,ICER)进行成本-效果分析。结果经倾向性评分匹配后,称重膳食组重复住院次数、住院天数、降糖药物费用和总成本均低于非称重膳食组,其中称重膳食组平均总成本(19 985.63元)比非称重组(21 538.60元)少1552.97元,且降糖效果高0.79 mmol/L,ICER等于-1965.78。结论 与非称重膳食疗法相比,应用称重膳食治疗2型糖尿病具有成本效果优势,建议在临床进一步推广应用。[营养学报,2022,44(5):505-509]Objective To evaluate the cost-effectiveness of weighed diet therapy versus non-weighed diet therapy for the treatment of type 2 diabetes mellitus(T2DM). Methods We selected 621 T2DM inpatients from January to December 2020 Information on cost, efficacy, and disease status basing on an electronic case system was collected, and cost-effectiveness analysis by calculating incremental cost-effectiveness ratios(ICER) was conducted. Results Hospital readmissions, length of hospital stay, cost of glucose-lowering medication, and total cost were lower in the weighed diet therapy group than in the non-weighed diet therapy group after propensity score matching. The weighed diet therapy group not only saved 1552.97 RMB, but also reduced blood glucose value by 0.79 mmol/L, with an ICER equal to-1965.78.Conclusion The application of weighed diet therapy for the treatment of T2DM has cost-effectiveness advantages over non-weighed diet therapy and should be recommended for further clinical application. [ACTA NUTRIMENTA SINICA, 2022,44(5):505-509]

关 键 词：2型糖尿病 医疗膳食 成本效果分析 经济负担 倾向性评分匹配分析 

分 类 号：R459.3[医药卫生—治疗学]